4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001226488-17-000005
Director sold 30,000 shares at an average $30.30 ($909,040)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HENDERSON JOHN T · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-09-01 | Exercise or conversion : show line 1 in the form | +10,000 | $16.46 | $164,600 | 52,524 | D |
| 2017-09-01 | Sale : show line 2 in the form | −10,000 | $30.31 | $303,056 | 42,524 | D |
| 2017-09-01 | Exercise or conversion : show line 3 in the form | +10,000 | $16.46 | $164,600 | 52,524 | D |
| 2017-09-01 | Sale : show line 4 in the form | −10,000 | $30.30 | $303,003 | 42,524 | D |
| 2017-09-01 | Exercise or conversion : show line 5 in the form | +10,000 | $16.46 | $164,600 | 52,524 | D |
| 2017-09-01 | Sale : show line 6 in the form | −10,000 | $30.30 | $302,981 | 42,524 | D |
| Open-market sales · 30,000 sh · avg $30.30 · $909,040 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-09-01 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | −10,000 | $16.46 | 2017-11-15 | 10,000 | 20,000 | D |
| 2017-09-01 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | −10,000 | $16.46 | 2017-11-15 | 10,000 | 10,000 | D |
| 2017-09-01 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −10,000 | $16.46 | 2017-11-15 | 10,000 | 0 | D |
Loading xslF345X03/edgardoc.xml…